Detailed text transcripts for TV channel - MSNBC - 20210614:15:38:00
Here is good news. the u.s. could be on track to approve a fourth covid vaccine. that's because the maryland-based biotech company novavax announced strong results from its phase three trials. the vaccine showed a 90% efficacy rate against the virus and it is 100% effective against moderate to severe covid. it will apply for fda emergency use authorization within the next few months. the u.s. has enough doses of the three vaccines approved to vaccinate the entire u.s. population. a fourth vaccine could help in getting doses to the rest of the world. so far in the u.s., nearly 144 million peopl...